Melanocytes as Instigators and Victims of Oxidative Stress  by Denat, Laurence et al.
Melanocytes as Instigators and Victims of Oxidative Stress
Laurence Denat1,4, Ana L. Kadekaro2,4, Laurent Marrot1, Sancy A. Leachman3 and Zalfa A. Abdel-Malek2
Epidermal melanocytes are particularly vulnerable to
oxidative stress owing to the pro-oxidant state gener-
ated during melanin synthesis, and to the intrinsic
antioxidant defenses that are compromised in patho-
logic conditions. Melanoma is thought to be oxidative
stress driven, and melanocyte death in vitiligo is
thought to be instigated by a highly pro-oxidant state
in the epidermis. We review the current knowledge
about melanin and the redox state of melanocytes,
how paracrine factors help counteract oxidative stress,
the role of oxidative stress in melanoma initiation and
progression and in melanocyte death in vitiligo, and
how this knowledge can be harnessed for melanoma
and vitiligo treatment.
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INTRODUCTION
Oxidative stress results from the overproduction of pro-oxidant
species in cells, and/or reduction of cellular antioxidant
capacity, and it can damage nucleic acids, lipids, and
proteins, leading to mutagenesis or cell death (Sander et al.,
2004). Reactive oxygen species (ROS) are produced by
mitochondria and peroxisomes during normal cellular
metabolic processes. The ROS production may be
accentuated under pathologic conditions, such as
inflammation and cancer, as well as upon exposure to
exogenous factors, such as UV or chemicals (Zhang et al.,
1997; Klaunig and Kamendulis, 2004; Sander et al., 2004;
Klaunig et al., 2009). Skin is the largest organ that interfaces
with the environment, and a major source of ROS that are
induced by sun exposure. Epidermal melanocytes are
particularly vulnerable to excessive ROS production owing
to their specialized function: melanin synthesis, which is
stimulated by sun exposure, during the process of tanning,
and by inflammation that results in postinflammatory
hyperpigmentation (Figure 1,2). Oxidative stress can disrupt
the homeostasis of (Figure 2) melanocytes, compromising their
survival or leading to their malignant transformation (Picardo
et al., 1996a; Schallreuter et al., 1999; Govindarajan et al.,
2002; Casp et al., 2002a; Gavalas et al., 2006; Fried and
Arbiser, 2008; Guan et al., 2008).
MELANIN AND THE REDOX STATE OF MELANOCYTES
Melanin synthesis involves oxidation reactions and superoxide
anion (O2
 ) and hydrogen peroxide (H2O2) generation, which
subject melanocytes to oxidative stress (Figure 1) (Koga et al.,
1992; Simon et al., 2009). Confinement of melanin synthesis
to melanosomes protects other cellular components from
oxidative damage. Tyrosinase, the rate-limiting enzyme for
melanin synthesis, oxidizes tyrosine to dopa, and dopa to
dopaquinone, a specific orthoquinone that can react with
nucleophilic compounds such as thiols or amino groups. The
catalytic activity of tyrosinase results in the generation of O2

(Tomita et al., 1984; Koga et al., 1992). Dopaquinone is
converted into dopachrome through a redox exchange. After
spontaneous decarboxylation, dopachrome either generates
dihydroxyindole (5,6-DHI), which is oxidized into indole
quinone, or produces dihydroxyindole carboxylic acid
(5,6-DHICA) after tautomerisation by tyrosinase-related
protein 2 (TRP2), and 5,6-DHICA is then converted into the
corresponding quinone. Moreover, TRP2 protects against
oxidative stress by increasing glutathione levels and by
reducing the toxicity of quinones and DNA damage induced
by free radicals (Michard et al., 2008). The redox cycling from
indoles to quinones generates ROS (Nappi and Vass, 1996).
Polymerization of these reactive quinones finally leads to the
formation of the brown/black eumelanin. The red-yellow
pheomelanin differs from eumelanin in that it has a higher
ratio of sulfur to quinones, and its synthesis involves the
generation of cysteinyl-dopa (instead of dopa), which is
converted into benzothiazine derivatives. These differences
account for the higher sunlight-induced pro-oxidant property
of pheomelanin compared with eumelanin.
In the skin, the balance between the pro-oxidant and
antioxidant properties of melanin are mainly determined by
the relative eumelanin and pheomelanin contents, the levels
of melanin intermediates, and the concentrations of reactive
metals within the melanosome microenvironment (Di Donato
et al., 2002; Liu et al., 2005). There are conflicting reports
about the role of melanin or melanin intermediates as pro-
oxidants or antioxidants. Constitutive pigmentation is reported
to correlate directly with catalase activity in cultured human
melanocytes, and with the levels of thioredoxin reductase in
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human skin (Maresca et al., 2008). Generation of H2O2 in
response to UV correlates inversely with constitutive pigmen-
tation, suggesting an antioxidant effect of melanin (Song et al.,
2009). In comparison with keratinocytes, the induction of 8-
hydroxydeoxyguanosine (8-OHdG), a major form of oxidative
DNA damage, and expression of several base excision repair
(BER) genes are higher in melanocytes (Mouret et al., 2012).
Paradoxically, cultured human melanocytes with high
melanin content are reported to be more vulnerable to
UVA-induced, but less susceptible to H2O2-induced,
oxidative DNA damage than their counterparts with low
melanin content (Hoogduijn et al., 2004; Wang et al.,
2010). Stimulation of melanogenesis in human melanocytes
or mouse melanoma cells is reported to increase UVA-
induced DNA damage (Wenczl et al., 1998; Kvam and
Tyrrell, 1999; Marrot et al., 1999). In contrast, stimulation of
melanogenesis in cultured human melanocytes by a-
melanocortin (a-MSH) increases the activity and protein
levels of catalase, and markedly reduces UV-induced H2O2
generation (Maresca et al., 2008; Song et al., 2009). In human
melanoma cells, increased pigmentation protects against UV-
or H2O2-induced mitochondrial DNA damage (Swalwell
et al., 2011). The controversy about the pro-oxidant versus
the antioxidant effects of melanin and its intermediates is
fueled by reports using purified melanin or melanin
intermediates exogenously added to cultured cells or naked
DNA (Tomita et al., 1984; Kipp and Young, 1999; Kovacs
et al., 2012). Although these data support the oxidative nature
of melanin, the experimental conditions used are unlikely to
be physiologically relevant, as melanin is normally confined
in melanosomes.
ACTIVATION OF ANTIOXIDANT DEFENSES IN
MELANOCYTES BY PARACRINE FACTORS
The homeostasis of epidermal human melanocytes is main-
tained primarily by a complex paracrine network consisting
of growth factors and cytokines synthesized by epidermal
keratinocytes and dermal fibroblasts, and modulated by UV.
The keratinocyte-derived endothelin-1 is a potent mitogen
and melanogenic factor that reduces H2O2 generation and
apoptosis in UV-irradiated human melanocytes (Imokawa
et al., 1992; Tada et al., 1998; Kadekaro et al., 2005).
The melanocortins a-MSH and ACTH are synthesized by
keratinocytes and melanocytes, and they stimulate eumela-
nin synthesis and melanocyte survival and proliferation by
binding and activating the melanocortin 1 receptor (MC1R).
The MC1R is a Gs protein–coupled receptor expressed on the
cell surface of melanocytes. Treatment of cultured human
melanocytes with a-MSH results in rapid reduction in the
generation of H2O2 in response to UV exposure, consistent
with earlier findings by Haycock et al. (Haycock et al., 2000;
Kadekaro et al., 2005; Song et al., 2009; Kadekaro et al.,
2010). In addition, a-MSH increases the protein and activity
levels of catalase, and counteracts the inhibitory effect of UV
on this enzyme (Song et al., 2009). Subsequently, treatment
with a-MSH reduces the induction of 8-oxodG and enhances
its repair in UV-irradiated melanocytes, and also reduces
oxidative DNA damage induced by H2O2 (Song et al., 2009;
Kadekaro et al., 2012). The antioxidant effects of a-MSH
require binding and activation of MC1R, are absent in melano-
cytes expressing loss-of-function MC1R, and are inhibited by
agouti signaling protein, the physiological MC1R antagonist
(Song et al., 2009). These results establish the significance
of the activated MC1R in protection of melanocytes from
oxidative stress.
Activation of p53 is an important mechanism by which the
activated MC1R reduces oxidative stress in melanocytes. It is
noteworthy that p53 regulates pigmentation by increasing the
expression of tyrosinase in human melanocytes and proopio-
melanocortin, the precursor for melanocortins, in mouse
keratinocytes (Cui et al., 2007). Activation of the MC1R by
a-MSH binding augments the UV-induced accumulation of
p53 in human melanocytes by increasing phosphorylation of
p53 on Ser15. Treatment with a-MSH also increases the levels
of the BER enzymes OGG1 and APE-1 by a p53-dependent
mechanism (Kadekaro et al., 2012).
In addition, activation of MC1R by a-MSH regulates
intracellular redox status by upregulating the expression of
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Figure 1. Generation of reactive oxygen species (ROS) by the various steps in
the melanin synthetic pathway.
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Figure 2. Induction of reactive oxygen species (ROS) by endogenous and
exogenous sources and antioxidant defenses that restore normal redox state
in melanocytes.
L Denat et al.
Melanocytes as Investigators and Victims of Oxidative Stress
www.jidonline.org 1513
antioxidant genes, including heme oxygenase-1 (HO-1), ferri-
tin, and peroxiredoxin-1 (Song et al., 2009; Kadekaro et al.,
2010). a-MSH activates a number of transcription factors
known to regulate the redox state of melanocytes. In normal
human melanocytes and melanoma cells, the redox sensor
APE-1 is a target of Mitf, the master regulator of melanocyte
survival and function (Liu et al., 2009). Treatment of human
melanocytes with a-MSH upregulates Mitf and APE-1
(Kadekaro et al., 2005, 2012). Melanocytes also express
Nrf-2, an important transcription factor that upregulates the
expression of genes for phase II detoxification enzymes, and
its main target HO-1 (Marrot et al., 2008; Kaspar et al., 2009;
Jain et al., 2010; Jian et al., 2011; Taguchi et al., 2011).
In addition, a-MSH increases the expression of Nrf-2 gene
and its target genes HO-1, y-glutamylcysteine-synthetase, and
glutathione S-transferase Pi in cultured human melanocytes,
and abrogates the inhibitory effects of UV on Nrf-2 and its
targets (Kokot et al., 2009). Another transcription factor that is
activated by a-MSH is NFkB, which is known to be activated
by TNF-a and ROS (Manna and Aggarwal, 1998; Ichiyama
et al., 1999; Haycock et al., 2000). Treatment of melanocytes
with a-MSH inhibits UV-induced apoptosis by increasing the
protein levels of Bcl2, a known target of NFkB and Mitf (Bohm
et al., 2005; Kadekaro et al., 2005).
SIGNIFICANCE OF OXIDATIVE STRESS IN MELANOMA
Sunlight is a major inducer of ROS formation in the skin and
a major contributor to skin cancer (Sander et al., 2004).
Irradiation of the skin by UVA and/or UVB impairs natural
antioxidant defenses and induces high levels of ROS.
Acute exposure to UV is the main etiological factor for
melanomagenesis. Irradiation of cultured human melano-
cytes with UV (75% UVB, 25% UVA) results in rapid dose-
dependent generation of H2O2 (van der Kemp et al., 2002);
(van der Kemp et al., 2002), and subsequent decrease in
catalase activity and protein levels, and reduced HO-1
expression (Kadekaro et al., 2005; Kokot et al., 2009; Song
et al., 2009; Kadekaro et al., 2010, 2012). Exposure of human
OGG1 protein, an important BER enzyme, to UVB results in
its inactivation (van der Kemp et al., 2002).
There is increasing evidence for the significance of oxida-
tive stress in the initiation and progression of melanoma. The
role of oxidative stress in melanoma is supported by the
findings that mutations in several melanoma-associated genes
result from, or exacerbate, oxidative stress. The activating
V600EBRAF mutation, a somatic mutation commonly expressed
in nevi and melanoma, may be oxidative stress–induced
(Landi et al., 2006). In melanocytes, p16 is an important
regulator of oxidative stress, and its depletion in cultured
human melanocytes significantly increases ROS levels (Jenkins
et al., 2011). Melanocytes are more sensitive to p16 depletion
than either keratinocytes or fibroblasts, which may impart the
association of p16 mutations with melanoma. Loss of PTEN is
associated with melanoma progression, presumably owing to
increased superoxide anion resulting from sustained activation
of Akt (Govindarajan et al., 2007). Loss-of-function alleles of
the MC1R that are associated with increased melanoma risk
cause sustained oxidative stress in human melanocytes owing
to the inability to respond to a-MSH (Kadekaro et al., 2010).
In addition, oxidative stress can impair nucleotide excision
repair, the main repair pathway for UV-induced DNA
photoproducts, via lipid peroxidation products that inactivate
DNA repair enzymes (Feng et al., 2004, 2006). Null
polymorphisms of GSTM1 and GSTT1 that belong to the
glutathione S-transferase family of antioxidant genes have
been associated with a high risk of melanoma, especially in
subjects with a history of sunburns in childhood (Fortes et al.,
2011). One single nucleotide polymorphism in the glutathione
S-transferase gene GSTP1, which reduces the activity of the
enzyme, has been associated with melanoma susceptibility
and with further increase in melanoma risk when coexpressed
with MC1R variant alleles (Ibarrola-Villava et al., 2012). These
results strongly suggest that oxidative stress is a driver of
melanomagenesis (Cassidy et al., 2013).
There is increasing evidence for aberrant redox state in
melanoma. Melanocytes derived from melanoma patients
display increased sensitivity to oxidizing agents owing to
endogenous antioxidant imbalance (Picardo et al., 1996b;
Grammatico et al., 1998; Picardo et al., 1999; Meyskens et al.,
2001). Melanoma tumor cells have higher intracellular levels
of O2
 compared with normal melanocytes, and they
aberrantly activate the transcription factors NF-kB and AP-1
(Meyskens et al., 2001). Moreover, melanoma tumor cells
express higher levels of neuronal nitric oxide synthase, thus
generating higher levels of nitric oxide than normal
melanocytes, and this increase correlates with the disease
stage in melanoma (Yang et al., 2013). The significance of
oxidative stress in melanoma is further supported by the
finding that the antioxidant N-acetylcysteine inhibits tumor
formation in the HGF-survivin melanoma mouse model
(Cotter et al., 2007), and selective inhibitors of neuronal
nitric oxide synthase inhibit melanoma cell growth and
metastatic potential (Yang et al., 2013). Accordingly, anti-
oxidants are being considered for the prevention, as well as for
the treatment, of melanoma.
The association of aberrant melanin synthesis with oxidative
stress and melanoma has been investigated by several research
teams. Dysplastic nevi that are precursors for melanoma have
increased ROS, and high pheomelanin, sulfur, iron, and
calcium levels, and DNA damage (Salopek et al., 1991;
Pavel et al., 2004; Smit et al., 2008). Noonan et al., 2012
reported that the frequency of UVA-induced melanoma
tumors in HGF mice increases with skin pigmentation via an
oxidative process involving melanin photoreactivity (Noonan
et al., 2012). Conversely, tumor formation in HGF mice is
inhibited by the antioxidant N-acetylcysteine (Cotter et al.,
2007). In human skin, UVA-induced pigmentation was found
to lack photoprotective properties (Miyamura et al., 2011),
indicating that exposure to UVA (e.g., in tanning beds) is not
a safe practice. Recently, Mitra et al., 2012 observed that
recessive yellow mice with loss-of-function mc1r and
coexpressing activating BRAFv600E mutation develop more
invasive melanoma tumors than their albino counterparts,
and that pheomelanin results in oxidative DNA damage (Mitra
et al., 2012). They concluded that oxidative DNA damage
resulting from pheomelanin synthesis is causal for melanoma,
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independently of UV exposure. How these findings apply
to human pigmentation and melanoma deserves to be
investigated, as human melanocytes synthesize both
eumelanin and pheomelanin unlike recessive yellow mouse
melanocytes that only synthesize pheomelanin. The ratio of
these pigments should determine the overall effects on the
redox state of melanocytes particularly upon UV exposure.
In addition, eumelanin and pheomelanin, as well as their
intermediates, might differ chemically in human vs. mouse
melanocytes, which might affect their pro-oxidant or
antioxidant properties. Given that eumelanin is a scavenger
of ROS (Meredith and Sarna, 2006), it can be concluded that
reduction of eumelanin, as in individuals with fair skin, or the
absence of eumelanin, as in recessive yellow mice, potentiates
melanoma risk by increasing the vulnerability of melanocytes
to oxidative stress.
OXIDATIVE STRESS AND LOSS OF MELANOCYTES IN
VITILIGO
Vitiligo is a depigmentary disease that occurs in B0.5% of
the world population, and it is characterized by the loss of
melanocytes in the epidermis by an autoimmune mechanism
(Taieb and Picardo, 2007; Spritz, 2013). However, there is
strong evidence for the role of oxidative stress as a key factor
in the onset and progression of the disease. Increased
sensitivity of melanocytes from vitiligo patients to UVB-
induced cell death as compared with normal melanocytes
was attributed to their compromised capacity to cope with
increased oxidative stress (Jimbow et al., 2001). Further
evidence supports the exaggerated sensitivity of melanocytes
from nonlesional vitiligo skin to chemical or physical
oxidative stress (Maresca et al., 1997; Boissy and Manga,
2004). Vitiligo patients are known to have very high levels of
H2O2 (1 mM) and peroxynitrite in their epidermis, concomitant
with reduced levels and activity of catalase (Schallreuter et al.,
1991; Maresca et al., 1997; Schallreuter et al., 1999, 2012).
High levels of H2O2 inactivate and reduce the levels of
methionine sulfoxide reductase A and B, and thioredoxin/
thioredoxin reductase, thus contributing to oxidative stress and
melanocyte death in vitiligo (Schallreuter et al., 2008; Zhou
et al., 2009). In addition, high levels of H2O2 in the epidermis
are found to oxidize proopiomelanocortin-derived bioactive
peptides ACTH and a-MSH, both of which have antioxidant
and survival effects on human melanocytes, and this effect can
be mitigated by treatment with pseudocatalase (Kadekaro
et al., 2005; Spencer et al., 2007; Kadekaro et al., 2010).
These findings suggest that the pro-oxidant state of vitiligo skin
is causal for melanocyte death.
The transcription factor Nrf-2 is implicated in the pathogen-
esis of vitiligo. An allelic variant of the Nrf-2 gene, A 650, is
thought to be a risk factor for vitiligo (Guan et al., 2008). More
recently, Natarajan et al., 2010 reported increased transcript
levels of Nrf-2, as well as its targets NQO-1, y-glutamyl
cysteine ligase catalytic, and modulatory subunits (GCLC and
GCLM, respectively) in vitiligo lesional epidermis, as
compared with nonlesional skin (Natarajan et al., 2010).
However, induction of Nrf-2, and its target genes HO-1,
NQO-1, GCLC, and GCLM, by the electrophilic compounds
curcumin and santalol is evident in nonlesional skin, but
not in lesional vitiligo skin, further confirming the disruption
of redox homeostasis in vitiligo (Natarajan et al., 2010).
Treatment of vitiligo patients with PUVA increases the
expression of the Nrf-2 target HO-1 in the skin (Elassiuty
et al., 2011). Comparison of cultured nonlesional vitiligo
melanocytes with their normal counterpart shows that the
former exhibit greater induction of HO-1 than the latter in
response to exposure to UVA or the phenolic compound
4-Tertiary butylphenol, demonstrating increased sensitivity of
vitiligo-derived melanocytes to oxidative stress.
In vitiligo, oxidative stress–induced death of melanocytes
is exacerbated by abnormal levels and/or activities of other
antioxidant and BER enzymes. Catalase allelic variants have
been associated with vitiligo, and the levels of several
antioxidant enzymes, such as catalase, glutathione peroxidase,
and glutathione reductase, have been found to be altered in
vitiligo, which account for sustained high levels of H2O2 in
the epidermis (Casp et al., 2002b; Gavalas et al., 2006; Park
et al., 2006). Salem et al. 2009 showed that in both lesional
and nonlesional vitiligo skin the levels of the BER enzymes
OGG1, APE-1, and DNA polymerase b are increased (Salem
et al., 2009). In addition to high levels of H2O2, high levels
of inducible nitric oxide synthase (iNos) in lesional and
nonlesional skin, and increased 8-oxoG in the skin and
plasma of vitiligo patients, can be detected, further
indicating generalized oxidative stress in vitiligo.
TARGETING OXIDATIVE STRESS PATHWAYS FOR
TREATMENT OF MELANOMA AND VITILIGO
A major benefit to understanding redox-related mechanisms
occurring in healthy and diseased melanocytes is the capacity
to harness these pathways for effective, targeted therapies and
prevention measures. Repigmentation of depigmented skin of
vitiligo, characterized by high levels of epidermal H2O2 and
peroxynitrite, is achieved by reducing H2O2, such as with
application of narrow-band UVB-activated pseudocatalase
(Schallreuter et al., 2013). For treatment of melanoma,
characterized by aberrant redox state, two different strategies
were proposed (Fruehauf and Meyskens, 2007). The first
strategy is to use agents that increase ROS scavenging to
reduce melanoma tumor growth by inhibiting H2O2 signaling,
which mediates the proliferative effects of growth factors and
inhibits the activity of protein tyrosine phosphatases, such
as PTEN. Overexpression of superoxide dismutase, gluta-
thione peroxidase, or catalase reduces tumor cell growth
(Venkataraman et al., 2005; Finch et al., 2006; Liu et al.,
2006). There is increasing evidence for the efficacy of
antioxidants as chemopreventative agents that inhibit
melanoma onset and progression. Administration of the
antioxidant NAC or selenium delays the onset of UV-
induced melanoma tumors (Cotter et al., 2007; Cassidy
et al., 2013). Honikiol, a potent scavenger of superoxide
and peroxyl radicals, inhibits melanoma cell growth in vitro
(Dikalov et al., 2008; Mannal et al., 2011). Selective inhibitors
of nitric oxide reduce melanoma cell growth and metastasis
(Yang et al., 2013). Selenium, which increases glutathione
peroxidase activity and the levels of glutathione, also
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decreases the size of human melanoma xenografts in vivo, and
inhibits the growth of human melanoma cells in vitro (Cassidy
et al., 2013). Treatment of human melanoma cell lines with
cAMP inducers, such as a-MSH, inhibits their proliferation,
partly owing to the inhibition of oxidative stress (Lyons et al.,
2013). The second strategy is to treat melanoma tumors
with agents that trigger apoptosis by compromising ROS
scavenging. Such agents include butathionine sulfoximine,
which depletes GSH, and disulfiram, which inhibits copper,
zinc superoxide dismutase, both of which inhibit melanoma
cell proliferation in vitro (Fruehauf et al., 1998; Cen et al.,
2004). In addition, quercetin, motexafin gadolinium, mel-
phalan, and cisplatin, which inhibit thioredoxin, are effective
in killing cancer cells (Witte et al., 2005; Hashemy et al.,
2006; Lu et al., 2006). Resveratrol, known to inhibit APE-1/
Ref-1 endonuclease activity, sensitizes melanoma cells to
DNA alkylating agents (Yang et al., 2005). Combined
therapy using some of the above agents can synergistically
inhibit melanoma tumor growth. Understanding the comple-
xity of oxidative stress pathways in pigmentation production,
melanocyte proliferation, and malignant transformation
has enormous potential to expand our armamentarium of
clinically effective compounds and offer enormous promise
for patients suffering from pigmentary disorders and
melanoma.
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